@article{1714afd05e9b4af5a2821d2e674a652d,
title = "From the Choice of a Regimen to the Choice of an Intensity: Changing Perspective in the Antithrombotic Therapy of Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention",
abstract = "NA",
keywords = "Anticoagulants, Atrial Fibrillation, Clinical Decision-Making, Coronary Artery Disease, Drug Therapy, Combination, Drug Utilization, Dual Anti-Platelet Therapy, Fibrinolytic Agents, Hemorrhage, Humans, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Practice Patterns, Physicians', Risk Factors, Treatment Outcome, Anticoagulants, Atrial Fibrillation, Clinical Decision-Making, Coronary Artery Disease, Drug Therapy, Combination, Drug Utilization, Dual Anti-Platelet Therapy, Fibrinolytic Agents, Hemorrhage, Humans, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Practice Patterns, Physicians', Risk Factors, Treatment Outcome",
author = "Andrea Rubboli and Elena Barbaresi and Bianca Rocca",
year = "2020",
doi = "10.1007/s10557-019-06903-y",
language = "English",
volume = "34",
pages = "143--144",
journal = "Cardiovascular Drugs and Therapy",
issn = "0920-3206",
publisher = "Kluwer Academic Publishers / Massachusetts:PO Box 358, Accord Station:Hingham, MA 02018:(617)871-6600",
}